Neither CD3 × BCMA × DU nor CD3 × DU × BCMA antibodies demonstrated any detectable on-target off-tumor activity (Fig. 2e and Extended Data Fig. 3b). The gene discussed is TNFRSF17; the disease is neoplasm.